Target intelligence / Profile preview

T helper cell (CD4-positive T lymphocyte) (CD4+ T cell)

Target
CD4+ T cell
Molecular classification
Other (cell type; not a canonical target class such as receptor, enzyme, etc.)
01

Overview

CD4-positive T lymphocytes, also called T helper cells, are a major subset of T cells characterized by expression of the CD4 surface molecule. They orchestrate and modulate adaptive immune responses by recognizing antigens presented by MHC class II molecules on antigen-presenting cells. Upon activation, these cells differentiate into multiple effector subsets (e.g., Th1, Th2, Th17, Treg) that direct diverse immune functions mainly via cytokine secretion. Modulation of their responses—through intrinsic or extrinsic signals—plays a central role in immunity against pathogens, tumor immunity, autoimmunity, and inflammatory diseases. While they are a primary target for immunomodulatory therapies, "CD4+ T lymphocyte response modulation" is not itself a molecular target, but encompasses various pathways and receptors involved in controlling CD4+ T cell activity.

Other names
Helper T cellT helper lymphocyteCD4-positive T lymphocyte
02

Mechanism of action

Cytokine modulation: Drugs like IL-2 act through receptor-mediated stimulation, expanding or activating CD4+ T lymphocytes.\nImmune checkpoint inhibition: Antibodies block inhibitory pathways, enhancing CD4+ T cell activation.\nImmunosuppression: Agents like cyclosporine or steroids inhibit signaling pathways required for CD4+ T cell function.

03

Biological functions

Immune responseImmune modulationCytokine secretionCell signalingMemory response
04

Disease associations

CancerInfectionInflammationAutoimmune diseaseOther (broad involvement in most immune pathologies)
05

Safety considerations

Autoimmunity (enhanced CD4+ T cell activation may trigger or worsen autoimmunity)Immunodeficiency (over-suppression can lead to infection risk)Cytokine release syndrome (excessive immune stimulation)
06

Interacting drugs

Interleukin-2 (IL-2; immunotherapies that modulate T cell function)

4 more in the full profile.

07

Biomarkers

CD4 surface protein expression (flow cytometry enumeration)Cytokine levels (e.g. IL-2, IFN-γ, IL-4, IL-17)Gene expression signatures of CD4+ T cell activation/subtypes

Beyond the preview

Go deeper on T helper cell (CD4-positive T lymphocyte) (CD4+ T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T helper cell (CD4-positive T lymphocyte) (CD4+ T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call